- Home
- CDIO vs XPON Comparison
CDIO vs XPON Comparison
Compare CDIO & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- XPON
- Stock Information
- Founded
- CDIO 2017
- XPON 2016
- Country
- CDIO United States
- XPON United States
- Employees
- CDIO N/A
- XPON N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- XPON Electronic Components
- Sector
- CDIO Health Care
- XPON Technology
- Exchange
- CDIO Nasdaq
- XPON Nasdaq
- Market Cap
- CDIO 6.4M
- XPON 6.2M
- IPO Year
- CDIO N/A
- XPON 2022
- Fundamental
- Price
- CDIO $3.76
- XPON $1.24
- Analyst Decision
- CDIO
- XPON
- Analyst Count
- CDIO 0
- XPON 0
- Target Price
- CDIO N/A
- XPON N/A
- AVG Volume (30 Days)
- CDIO 29.6K
- XPON 22.5M
- Earning Date
- CDIO 08-14-2025
- XPON 08-13-2025
- Dividend Yield
- CDIO N/A
- XPON N/A
- EPS Growth
- CDIO N/A
- XPON N/A
- EPS
- CDIO N/A
- XPON N/A
- Revenue
- CDIO $19,507.00
- XPON $8,414,250.00
- Revenue This Year
- CDIO $1,434.82
- XPON $61.26
- Revenue Next Year
- CDIO $4,661.91
- XPON N/A
- P/E Ratio
- CDIO N/A
- XPON N/A
- Revenue Growth
- CDIO N/A
- XPON 68.33
- 52 Week Low
- CDIO $3.22
- XPON $0.60
- 52 Week High
- CDIO $53.10
- XPON $22.81
- Technical
- Relative Strength Index (RSI)
- CDIO 47.81
- XPON 43.66
- Support Level
- CDIO $3.62
- XPON $1.11
- Resistance Level
- CDIO $3.99
- XPON $1.71
- Average True Range (ATR)
- CDIO 0.27
- XPON 0.18
- MACD
- CDIO 0.03
- XPON -0.06
- Stochastic Oscillator
- CDIO 68.00
- XPON 11.82
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.